课题基金 / 基金详情

How the proteasome works: resolving a critical new level of regulation

How the proteasome works: resolving a critical new level of regulation
蛋白酶体如何工作:解决关键的新监管水平
批准号:
BB/W016672/1
负责人:
Paula Da Fonseca
金额:
$68.0万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2023
资助国家:
英国
项目状态:
未结题
起止时间:
2023 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Proteasomes are essential cell regulators in all eukaryotes. They are involved in the turnover of most proteins by breaking down proteins that are old, damaged, or no longer needed. They also perform the highly regulated removal of specific proteins that signal to important and diverse events such as cell division, stress responses and chromatin maintenance. Despite 30 years of research, many of the fundamental aspects of proteasome function are still not fully characterised. We recently discovered an unexpected new level of proteasome regulation by divalent cations that challenges our current understanding of how the proteasome works. I want to build on our new data to unambiguously describe how proteasomes work inside the cells. For this I will use electron microscopy based structural analysis, together with biochemical and biophysical methods, to visualise in detail how they are regulated by divalent cations and how they recognise and process the proteins to be degraded. Because the proteasome is a critical cell regulator, understanding its fundamental working mechanisms will have a broad impact in biological sciences in general. The outputs of the proposed work have the potential of contributing to the clarification of critical mechanisms underlying conditions such as cancer progression, neurodegeneration, and aging, where proteasome dysfunction and calcium deregulation have been implicated, with impact for a wide range of beneficiaries. The proteasome is a well-established drug target for conditions including cancer, so in addition to improving basic knowledge the proposal has the potential to contribute to further developments in drug discovery and development.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
关于唐氏综合症关键区域1(DSCR1)蛋白降解途径及功能的研究
  • 批准号:
    30771075
  • 项目类别:
    面上项目
  • 资助金额:
    35.0万元
  • 批准年份:
    2007
  • 负责人:
    孙秀莲
  • 依托单位:
细胞内磷酸化tau蛋白降解途径的研究
  • 批准号:
    30500271
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2005
  • 负责人:
    张家玉
  • 依托单位:
脊髓小脑变性3型蛋白导致蛋白酶体功能障碍及其机制
  • 批准号:
    30470538
  • 项目类别:
    面上项目
  • 资助金额:
    25.0万元
  • 批准年份:
    2004
  • 负责人:
    王光辉
  • 依托单位:
proteasome抑制剂诱导恶性增殖白血病细胞凋亡的分子机制